Tommaso Saccardo

9PUBLICATIONS
24CO-AUTHORS
Gene and molecular therapyOtorhinolaryngologyPharmacogenomicsOther European literatureToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 18, 2025
Early real-life outcomes of dupilumab and mepolizumab in patients with uncontrolled primary diffuse type 2 chronic rhinosinusitis.

Tommaso Saccardo, Giuseppe Roccuzzo, Nicola Tessari

|Nov 12, 2024
Enlarged Frontal Sinusotomy and Chronic Rhinosinusitis with Nasal Polyps: An Effective Strategy to Control the Disease.

Tommaso Saccardo, Valentine Nicolas, Emilien Chebib

|May 25, 2024
The Impact of Dupilumab on Work Productivity and Emotional Health in CRSwNP: A Multicentric Study in Northeast Italy.

Giancarlo Ottaviano, Giuseppe Roccuzzo, Lucia Lora

|May 25, 2024
A Pathophysiological Approach to Spontaneous Orbital Meningoceles: Case Report and Systematic Review.

Piergiorgio Gaudioso, Elia Biancoli, Veronica Battistuzzi

|Aug 25, 2023
Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP.

Giancarlo Ottaviano, Eugenio De Corso, Tommaso Saccardo

|Feb 25, 2023
Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab.

Giancarlo Ottaviano, Eugenio De Corso, Elena Cantone

Pageof 2